IP Verse

Syringe

PatentPatent Analysis

EP2869813

NOVARTIS
Application Number
EP13701276A
Filing Date
Jan 25, 2013
Status
Revoked
Jul 29, 2022
Grant Date
Nov 21, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3143995B2
EP4321157B1
EP3487881B1

Bibliography

The patent EP2869813B1 was granted to Novartis on Nov 21, 2018 following the initial filing on Jan 25, 2013 under the application number EP13701276A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

DILGAug 21, 2019ADMISSIBLE
HOFFMANN EITLEAug 21, 2019ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents